Last checked at 
| UK Earnings, Trading Statements Calendar | |
| Thursday, August 14 | |
| Partnership Assurance Group | Half Year Results |
| Zoopla Property Group | Interim Management Statement |
| Centamin | Half Year Results |
| Cineworld Group | Half Year Results |
| Derwent London | Half Year Results |
| Ophir Energy | Half Year Results |
| Rank Group | Half Year Results |
| The Vitec Group | Half Year Results |
| Friday, August 15 | |
| No Events Scheduled | |
| Monday, August 18 | |
| Coalfield Resources | Half Year Results |
| Amlin | Half Year Results |
| Bovis Homes Group | Half Year Results |
| Clarkson | Half Year Results |
| Polypipe Group | Half Year Results |
| Tuesday, August 19 | |
| H&T Group | Half Year Results |
| Castings | Interim Management Statement |
| Mears Group | Half Year Results |
| Imperial Tobacco Group | Interim Management Statement |
| BHP Billiton | Full Year Results |
| Cairn Energy | Half Year Results |
| John Menzies | Half Year Results |
| Persimmon | Half Year Results |
| TT Electronics | Half Year Results |
| John Wood Group | Half Year Results |
| Wednesday, August 20 | |
| Carillion | Half Year Results |
| Harvey Nash Group | Trading statement |
| UK Commercial Property Trust | Half Year Results |
| Glencore | Half Year Results |
| Hikma Pharmaceuticals | Half Year Results |
| Copyright 2014 Alliance News Limited. All Rights Reserved. | |
27 Aug 2021 12:32
Hikma, Bio-Thera enter exclusive agreement for monoclonal antibody
(Sharecast News) - Bio-Thera Solutions and Hikma Pharmaceuticals have entered into a commercialisation and license agreement to commercialise a monoclonal antibody used for the treatment of Crohn's disease.
Read more